Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06294314 · ClinicalTrials.gov registry record

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

A clinical trial of Anterior Cruciate Ligament Rupture, sponsored by Marshall University.

Recruiting
Registry status
450
Enrollment target
1
Study location

NCT06294314 is a study of Anterior Cruciate Ligament Rupture that is actively recruiting participants, run by Marshall University. The registered enrollment target is 450 participants, above the 98-participant average among 9 other Anterior Cruciate Ligament Rupture trials with a reported enrollment target (359% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06294314, a study of Anterior Cruciate Ligament Rupture, is actively recruiting participants, sponsored by Marshall University.

RECRUITING
Registry status
450 participants
Enrollment target
1
Study location

Study Summary

The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information.

Interventions

  • PROCEDURE Fertilized ACL

Study Locations (1)

West Virginia

  • Marshall University - Huntington

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2024-02-26
Est. Completion 2028-07-01

Sponsor

Marshall University

12 total trials

What the Registry Record Tells You About NCT06294314

The ClinicalTrials.gov registry entry for NCT06294314 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 9 other Anterior Cruciate Ligament Rupture trials with a reported enrollment target (359% higher). The listed sponsor is Marshall University, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anterior Cruciate Ligament Rupture appearing as the primary indexed condition, and to 1 intervention - of which Fertilized ACL is the first listed.

NCT06294314 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.

Frequently Asked Questions

What is clinical trial NCT06294314 about?

NCT06294314 is a clinical study titled "Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace". The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information.

What is the current status of trial NCT06294314?

This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2024-02-26. Estimated completion is 2028-07-01.

What conditions does trial NCT06294314 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Rupture.

What interventions are being tested in trial NCT06294314?

The interventions under investigation include: Fertilized ACL (PROCEDURE).

Who is sponsoring clinical trial NCT06294314?

This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06294314 being conducted?

This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Rupture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.